# ADAP2

## Overview
ADAP2, or ArfGAP with dual PH domains 2, is a gene that encodes a protein involved in cellular signaling pathways, particularly in the regulation of immune responses and cellular structure. The protein encoded by ADAP2 is categorized as a GTPase-activating protein (GAP) and plays a pivotal role in the RIG-I signaling pathway, which is crucial for the production of type I interferons in response to viral infections. As a scaffolding protein, it facilitates the assembly of key signaling complexes, thereby enhancing antiviral defense mechanisms (Bist2017ArfGAP). Beyond its role in immune responses, ADAP2 is also implicated in the stabilization of microtubules, contributing to proper mitotic apparatus assembly (Zuccotti2012Centaurinα2). Clinically, alterations in the ADAP2 gene have been associated with cardiovascular malformations, particularly in the context of NF1 microdeletion syndrome, highlighting its significance in both immune function and developmental processes (Venturin2014ADAP2in).

## Function
ADAP2, a member of the ArfGAP family, plays a crucial role in the regulation of interferon responses in human cells. It acts as a positive regulator of RIG-I-mediated interferon gene transcription, particularly enhancing the production of type I interferons such as IFN-β in response to viral infections (Bist2017ArfGAP). ADAP2 functions as a scaffolding protein, facilitating the assembly of the MAVS-NEMO-TBK1-IRF3 complex, which is essential for the activation of interferon responses (Bist2017ArfGAP). This protein is necessary for the phosphorylation of IRF3, a transcription factor activated in response to viral infection, indicating its role upstream in the RIG-I signaling pathway (Bist2017ArfGAP).

ADAP2 interacts with several key proteins in the RIG-I pathway, including MAVS, NEMO, TBK1, and IRF3, and these interactions are independent of each other (Bist2017ArfGAP). The ArfGAP domain of ADAP2 is essential for its activity, mediating interactions with these proteins and supporting the interferon response (Bist2017ArfGAP). ADAP2's role in antiviral defense is underscored by its ability to enhance IFN-β gene transcription and its involvement in multiple signaling pathways downstream of RIG-I (Bist2017ArfGAP).

## Clinical Significance
The ADAP2 gene has been implicated in various clinical conditions, particularly in the context of NF1 microdeletion syndrome. This syndrome is characterized by a heterozygous deletion in the 17q11.2 region, which includes the ADAP2 gene, and is associated with a higher incidence of cardiovascular malformations (CVMs) compared to NF1 caused by intragenic mutations. Patients with NF1 microdeletion syndrome often present with more severe phenotypes, including pulmonic stenosis, atrial and ventricular septal defects, and valve defects. Studies suggest that ADAP2 haploinsufficiency may contribute to these valvular defects, such as mitral valve prolapse, pulmonary valve stenosis, and aortic valve anomalies, due to its role in heart development processes like cardiac jogging and D-looping (Venturin2014ADAP2in).

In addition to its role in cardiovascular development, ADAP2 is also involved in antiviral immune responses. It acts as a positive regulator of RIG-I-mediated interferon gene transcription, which is crucial for antiviral responses. Alterations in ADAP2 expression can affect the production of type I interferons, potentially impacting the host's ability to control viral infections (Bist2017ArfGAP). However, specific diseases directly linked to mutations or alterations in ADAP2 in this context are not detailed in the available literature.

## Interactions
ADAP2, also known as ArfGAP with dual PH domains 2, is involved in various protein interactions that are crucial for its role in cellular signaling pathways. It acts as a scaffolding protein in the RIG-I signaling pathway, facilitating the assembly of a complex involving MAVS, NEMO, TBK1, and IRF3, which is essential for type I interferon production. ADAP2 interacts with these proteins independently of each other, and its interaction is enhanced upon viral infection (Bist2017ArfGAP).

The ArfGAP domain of ADAP2 is critical for its interactions with the RIG-I pathway components, binding to specific regions of MAVS, NEMO, TBK1, and IRF3. For instance, it interacts with the N-terminal 100 amino acids of MAVS and the N-terminal 150 amino acids of NEMO (Bist2017ArfGAP). ADAP2 also binds to the C-terminal half of the IRF association domain of IRF3, facilitating its dimer formation upon phosphorylation (Bist2017ArfGAP).

In addition to its role in antiviral signaling, ADAP2, also known as Centaurin-α2, interacts with β-tubulin, promoting microtubule stability and proper mitotic apparatus assembly. This interaction involves the C-terminal region of β-tubulin and is confirmed by coimmunoprecipitation experiments (Zuccotti2012Centaurinα2).


## References


[1. (Bist2017ArfGAP) Pradeep Bist, Susana Soo-Yeon Kim, Niyas Kudukil Pulloor, Kathleen McCaffrey, Sajith Kumar Nair, Yiliu Liu, Rongtuan Lin, and Manoj N. Krishnan. Arfgap domain-containing protein 2 (adap2) integrates upstream and downstream modules of rig-i signaling and facilitates type i interferon production. Molecular and Cellular Biology, March 2017. URL: http://dx.doi.org/10.1128/MCB.00537-16, doi:10.1128/mcb.00537-16. This article has 17 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1128/MCB.00537-16)

[2. (Venturin2014ADAP2in) Marco Venturin, Silvia Carra, Germano Gaudenzi, Silvia Brunelli, Guido Roberto Gallo, Silvia Moncini, Franco Cotelli, and Paola Riva. Adap2in heart development: a candidate gene for the occurrence of cardiovascular malformations in nf1 microdeletion syndrome. Journal of Medical Genetics, 51(7):436–443, April 2014. URL: http://dx.doi.org/10.1136/jmedgenet-2013-102240, doi:10.1136/jmedgenet-2013-102240. This article has 28 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1136/jmedgenet-2013-102240)

[3. (Zuccotti2012Centaurinα2) Paola Zuccotti, Daniele Cartelli, Michela Stroppi, Vittorio Pandini, Marco Venturin, Alessandro Aliverti, Elena Battaglioli, Graziella Cappelletti, and Paola Riva. Centaurin-α2 interacts with β-tubulin and stabilizes microtubules. PLoS ONE, 7(12):e52867, December 2012. URL: http://dx.doi.org/10.1371/journal.pone.0052867, doi:10.1371/journal.pone.0052867. This article has 16 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0052867)